About THERALYTIX LLC
Theralytix is a company developing broad-spectrum bacteriophage cocktails to combat antibiotic-resistant bacterial infections. The company focuses on phage therapy as an alternative to traditional antibiotics, targeting a range of multidrug-resistant pathogens.
Development of broad-spectrum polyvalent bacteriophage cocktailsTargeting of multidrug-resistant bacterial pathogensSupply of phage components to third parties for use in various verticals
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| CLEARANCE OF PATHOGENS CAUSING DIARRHEA, DYSENTERY AND URINARY TRACT INFECTIONS | Department of Defense | $1.2M | |
| CLEARANCE OF PATHOGENS CAUSING DIARRHEA, DYSENTERY AND URINARY TRACT INFECTIONS | Department of Defense | $71K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to THERALYTIX LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.